Literature DB >> 28148654

Informed consent in the context of research involving acute injuries and emergencies.

M L Costa1, E Tutton2, J Achten1, R Grant3, A M Slowther4.   

Abstract

Traditionally, informed consent for clinical research involves the patient reading an approved Participant Information Sheet, considering the information presented and having as much time as they need to discuss the study information with their friends and relatives, their clinical care and the research teams. This system works well in the 'planned' or 'elective' setting. But what happens if the patient requires urgent treatment for an injury or emergency? This article reviews the legal framework which governs informed consent in the emergency setting, discusses how the approach taken may vary according to the details of the emergency and the treatment required, and reports on the patients' view of providing consent following a serious injury. We then provide some practical tips for managing the process of informed consent in the context of injuries and emergencies. Cite this article: Bone Joint J 2017;99-B:147-150. ©2017 The British Editorial Society of Bone & Joint Surgery.

Entities:  

Keywords:  Clinical research; Emergency; Informed consent; Mental capacity; Trauma

Mesh:

Year:  2017        PMID: 28148654     DOI: 10.1302/0301-620X.99B2.BJJ-2016-0517.R1

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  2 in total

1.  Participation in a trial in the emergency situation: a qualitative study of patient experience in the UK WOLLF trial.

Authors:  Elizabeth Tutton; Juul Achten; Sarah E Lamb; Keith Willett; Matthew L Costa
Journal:  Trials       Date:  2018-06-25       Impact factor: 2.279

2.  A randomized controlled trial comparing the Thompson hemiarthroplasty with the Exeter polished tapered stem and Unitrax modular head in the treatment of displaced intracapsular fractures of the hip: the WHiTE 3: HEMI Trial.

Authors:  A L Sims; N Parsons; J Achten; X L Griffin; M L Costa; M R Reed
Journal:  Bone Joint J       Date:  2018-03-01       Impact factor: 5.082

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.